Cell Therapies Competitors and Similar CompaniesClear all
Cimeio's competitors and similar companies include Precigen.
 Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. |  Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases. | |
Founding Date | Founding Date 2020 | Founding Date 1998 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Basel, CH HQ | Locations Germantown, US HQ Gent, BE Sioux Center, US |
Employees | Employees 21 | Employees 601 |
Funding | ||
Total funding raised | Total funding raised $ 50m | Total funding raised $ 379m |
For sources of this data, please see the company profile
View Company Profiles
Precigen
HQ
Germantown, US
Employees
601
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
View company